Organo : Consolidated Financial Results for the Fiscal Year Ended March 31, 2021 237KB (PDF)

DISCLAIMER: This translation may be used for reference purposes only. This English version is not an official translation of the original Japanese document. In cases where any differences occur between the English version and the original Japanese version, the Japanese version shall prevail. This translation is subject to change without notice.

	Consolidated Financial Results
	for the Fiscal Year Ended March 31, 2021
	May 11, 2021
Company name:	ORGANO CORPORATION
Listing:	Tokyo Stock Exchange
Securities code:	6368
URL:	https://www.organo.co.jp/english/
Representative:	Masaki Uchikura, Representative Director and President
Inquiries:	Minoru Ando, General Manager of Accounting Dept., Corporate Management and
	Planning
TEL:	[phone]

Scheduled date of ordinary general meeting of shareholders:	June 29, 2021
Scheduled date to commence dividend payments:	June 30, 2021
Scheduled date to file annual securities report:	June 29, 2021
Preparation of supplementary material on financial results:	Yes
Holding of financial results presentation meeting:	Yes (for institutional investors and
	analysts)

(Millions of yen with fractional amounts discarded, unless otherwise noted)

1. Consolidated financial results for the fiscal year ended March 31, 2021 (from April 1, 2020 to March 31, 2021)

(1) Consolidated operating results				(Percentages indicate year-on-year changes.)
		Net sales		Operating profit	Ordinary profit	Profit attributable to
			owners of parent
	Fiscal year ended	Millions of yen	%	Millions of yen	%	Millions of yen	%	Millions of yen	%
	March 31, 2021	100,638	4.3	9,579	(3.3)	9,900	(0.3)	7,074	(1.2)
	March 31, 2020	96,515	4.6	9,908	51.1	9,929	51.9	7,162	60.9

Note:

Comprehensive income: Fiscal year ended March 31, 2021

¥7,711 million [9.7%]

Fiscal year ended March 31, 2020

¥7,029 million [73.3%]

Basic earnings

Diluted earnings

Ratio of ordinary

Operating profit

Return on equity

profit to total

per share

per share

ratio

assets

Fiscal year ended

Yen

Yen

%

%

%

March 31, 2021

616.72

-

11.1

9.1

9.5

March 31, 2020

626.05

-

12.4

9.8

10.3

(Reference) Share of profit

(loss) of entities accounted for using equity method

Fiscal year ended March 31, 2021

¥153 million

Fiscal year ended March 31, 2020

¥170 million

(2) Consolidated financial position

Total assets

Net assets

Equity-to-asset ratio

Net assets per share

As of

Millions of yen

Millions of yen

%

Yen

March 31, 2021

115,011

67,357

58.4

5,856.25

March 31, 2020

101,448

60,857

59.9

5,301.26

(Reference) Equity: As of March 31, 2021

¥67,214 million

As of March 31, 2020

¥60,717 million

(3) Consolidated cash flows

	Cash flows from	Cash flows from	Cash flows from	Cash and cash
	equivalents
	operating activities	investing activities	financing activities
	at end of period
Fiscal year ended	Millions of yen	Millions of yen	Millions of yen	Millions of yen
March 31, 2021	(4,582)	(1,261)	4,927	12,804
March 31, 2020	8,553	(1,006)	(5,007)	13,772

2. Cash dividends

		Annual dividends per share		Total cash	Payout ratio	Ratio of
						dividends to
	First	Second	Third	Fiscal	Total	dividends
	quarter-end	quarter-end	quarter-end	year-end	(annual)	(consolidated)	net assets
			(consolidated)
	Yen	Yen	Yen	Yen	Yen	Millions of	%	%
	yen
Fiscal year ended	-	47.00	-	57.00	104.00	1,196	16.6	2.1
March 31, 2020
Fiscal year ended	-	52.00	-	62.00	114.00	1,311	18.5	2.0
March 31, 2021
Fiscal year ending
March 31, 2022	-	57.00	-	57.00	114.00		20.1
(Forecast)

3. Consolidated earnings forecasts for the fiscal year ending March 31, 2022 (from April 1, 2021 to March 31, 2022)

(Percentages indicate year-on-year changes.)

								Profit attributable to	Basic
	Net sales		Operating profit	Ordinary profit	earnings
		owners of parent
								per share
	Millions		%	Millions	%	Millions	%	Millions	%	Yen
	of yen		of yen	of yen	of yen
Six months ending	50,000		10.3	2,600	(18.3)	2,550	(22.2)	1,500	(27.9)	130.69
September 30, 2021
Fiscal year ending	103,000		2.3	8,250	(13.9)	8,150	(17.7)	6,500	(8.1)	566.33
March 31, 2022

* Notes

1. Changes in significant subsidiaries during the period (changes in specified subsidiaries resulting in the change in scope of consolidation): None
2. Changes in accounting policies, changes in accounting estimates, and restatement
3. 1. Changes in accounting policies due to revisions to accounting standards and other regulations: None
   2. Changes in accounting policies due to other reasons: None
   3. Changes in accounting estimates: None
   4. Restatement: None
4. Number of issued shares (common shares)
5. 1. Total number of issued shares at the end of the period (including treasury shares)

As of March 31, 2021	11,589,925 shares
As of March 31, 2020	11,589,925 shares

b. Number of treasury shares at the end of the period

As of March 31, 2021	112,618 shares
As of March 31, 2020	136,593 shares

c. Average number of shares outstanding during the period

For the fiscal year ended March 31, 2021	118,984 shares
For the fiscal year ended March 31, 2020	11,440,300 shares

The Company has introduced an Officer Share Delivery Trust, and shares of the Company held by the Trust have been included in treasury shares excluded from the calculation of the number of treasury shares at the end of the period and the average number of shares outstanding during the period.

[Reference] Overview of non-consolidated financial results

1. Non-consolidated financial results for the fiscal year ended March 31, 2021 (from April 1, 2020 to March 31, 2021)

(1) Non-consolidated operating results					(Percentages indicate year-on-year changes.)
	Net sales		Operating profit	Ordinary profit	Profit
Fiscal year ended	Millions of yen		%	Millions of yen		%	Millions of yen	%	Millions of yen	%
March 31, 2021	72,661		2.5	6,311		(7.3)	7,770	(4.7)	5,879	(4.6)
March 31, 2020	70,907		8.1	6,808		94.7	8,151	77.7	6,165	93.8
	Basic earnings		Diluted earnings
	per share		per share
Fiscal year ended			Yen			Yen
March 31, 2021	512.56			-
March 31, 2020	538.91			-

(2) Non-consolidated financial position

		Total assets	Net assets	Equity-to-asset ratio	Net assets per share
As of		Millions of yen	Millions of yen	%	Yen
March 31, 2021		97,582	56,547	57.9	4,926.90
March 31, 2020		85,650	51,743	60.4	4,517.80
(Reference) Equity:	As of March 31, 2021:	¥56,547 million
	As of March 31, 2020:	¥51,743 million

• Financial results reports are exempt from audit conducted by certified public accountants or an audit corporation.
• Proper use of earnings forecasts, and other special matters (Caution regarding forward-looking statements and others)
  The forward-looking statements, including earnings forecasts, contained in these materials are based on information currently available to the Company and on certain assumptions deemed to be reasonable. Consequently, any statements herein do not constitute assurances regarding actual results by the Company. Actual business and other results may differ substantially due to various factors. Please refer to "(4) Future outlook" in "1. Overview of operating results, etc." on page 6 of the attached material for the suppositions that form the assumptions for earnings forecasts and cautions concerning the use thereof.

Attached Material
	Index
1. Overview of operating results, etc. .........................................................................................................	2
(1)	Overview of operating results for the fiscal year under review .......................................................	2
(2)	Overview of financial position for the fiscal year under review ......................................................	5
(3)	Overview of cash flows for the fiscal year under review ..................................................................	6
(4)	Future outlook......................................................................................................................................	6
2. Basic policy regarding selection of accounting standards ....................................................................	7
3. Consolidated financial statements and significant notes thereto .........................................................	8
(1)	Consolidated balance sheet ................................................................................................................	8
(2)	Consolidated statement of income and consolidated statement of comprehensive income.........	10
	Consolidated statement of income...................................................................................................	10
	Consolidated statement of comprehensive income ........................................................................	11
(3)	Consolidated statement of changes in equity .................................................................................	12
(4)	Consolidated statement of cash flows .............................................................................................	14
(5)	Notes to consolidated financial statements .....................................................................................	16
	Notes on premise of going concern..................................................................................................	16
	Changes in presentation...................................................................................................................	16
	Additional information ....................................................................................................................	16
	Segment information, etc. ................................................................................................................	17
	Per share information ......................................................................................................................	20
	Significant subsequent events ..........................................................................................................	21

- 1 -